Broker Recommendations
Canaccord cuts profit forecasts on Beazley following California wildfires
Analysts at Canaccord Genuity took a fresh look at insurance and underwriting service Beazley on Friday, a day after the firm warned claims from the recent California wildfires had cost it roughly $40m.
Berenberg downgrades Centamin amid caution over 2019 guidance
Berenberg downgraded gold miner Centamin to ‘hold’ from ‘buy’ on Friday, cutting the price target to 106p from 115p, citing caution over 2019 guidance.
UBS downgrades BAE as budget risks loom in the face of Brexit
Analysts at UBS downgraded defence, security, and aerospace giant BAE Systems to 'neutral' on Thursday, noting the FTSE 100 constituent's organic growth prospects appeared "limited".
Liberum ups Barratt, Bovis and Crest Nicholson to 'buy'
Liberum upped its stance on Barratt Developments, Bovis Homes and Crest Nicholson on Thursday, arguing that there is at least 20% upside if a smooth Brexit materialises.
Broker tips: GlaxoSmithKline, Ted Baker, Pearson, Centrica
Barclays has cut GlaxoSmithKline to 'equalweight' from 'overweight' and trimmed the price target to 1,600p from 1,750p after the pharmaceuticals giant announced earlier in the week that it was selling its Horlicks business and other consumer health brands to Unilever for £3bn and buying US drug company Tesaro for $5. 1bn.
UBS downgrades Centrica on 'more balanced' risk/reward scenario
Analysts at UBS downgraded Centrica to 'neutral' on Wednesday, highlighting a "more balanced" risk/reward scenario in the wake of the FTSE 100 constituent's most recent trading update.
Disappointing results from Pearson rival bode badly, says Liberum
Liberum reiterated its 'sell' rating on education publisher Pearson on Wednesday, saying that disappointing second-quarter results from Barnes & Noble Education in the US provide warning signs.
Barclays downgrades Glaxo on Tesaro acquisition
Barclays has cut GlaxoSmithKline to 'equalweight' from 'overweight' and trimmed the price target to 1,600p from 1,750p after the pharmaceuticals giant announced earlier in the week that it was selling its Horlicks business and other consumer health brands to Unilever for £3bn and buying US drug company Tesaro for $5. 1bn.
HSBC downgrades Ted Baker, Liberum reiterates 'buy'
Analysts were divided in their opinions of Ted Baker's recent woes on Wednesday, with HSBC cutting its recommendation on the stock as Liberum reiterated its positive stance in the aftermath of the "forced hugging" scandal.
Credit Bank of Moscow sees further weakness ahead in the rouble
Russia's rouble may be headed lower in 2019, according to one of the country's top lenders, regardless of the nascent rebound in crude oil prices.
Liberum sees value in motor retailers amid 'sweeping changes'
Analysts at Liberum initiated coverage on several London-listed motor retailers on Tuesday, noting the motor industry was facing "sweeping changes" and a margin crunch.
HSBC cuts Apple to 'hold', cites market saturation
HSBC downgraded its stance tech giant Apple to 'hold' from 'buy' on Tuesday, trimming the target price to $200 from $205 as it pointed to its dependence on the iPhone and the saturation of the smartphone market.
Canaccord downgrades Kier as it accounts for rights issue, macro risks
FTSE 250 construction group Kier was under the cosh again on Tuesday as Canaccord Genuity cut its stance on the stock to 'hold' from 'buy' and slashed the price target to 525p from 1,200p to take into account the heavily-discounted rights issue announced last week and macro risks.
BT discount to peers unwarranted, says Goldman
BT's discount to peers is "increasingly unwarranted", Goldman Sachs said on Tuesday as it lifted the stock to 'buy' from 'neutral' and upped the price target to 320p from 240p, noting implied upside of 24. 7%.
Deutsche Bank ups Rightmove to 'buy', cites attractive valuation
Rightmove was the standout gainer on the FTSE 100 on Tuesday as Deutsche Bank upped the stock to 'buy' from 'hold' and lifted the target price to 530p from 440p, highlighting its attractive valuation.
Liberum cuts target price on McColl's following profit warning
Analysts at Liberum cut their target price on British convenience shop and newsagent operator McColl's Retail on Monday, citing persistent challenges in the group's supply chain.
Analysts rethink stance on Kier following shock rights issue
Analysts at Liberum put Kier under review on Monday, noting that, while it will give the construction services outfit a stronger balance sheet, last weeks' rights issue left the group's cash flow looking poor.
Peel Hunt says Dunelm set for recovery, ups to 'buy'
Homeware retailer Dunelm surged on Monday as Peel Hunt upped the stock to 'buy' from 'hold' and lifted the price target to 750p from 550p, citing catalysts for a recovery next year as the company sharpens up its act following a series of downgrades driven largely by the 2016 Worldstores acquisition.